The Journal of Organic Chemistry
Article
performed with cyclohexane/AcOEt: 10/0 to 95/5 as eluent and led to
the expected compound 2c (251 mg, 71%) as a colorless liquid: H
7-Bromo-2-chloro-3-trimethylsilylfuro[3,2-b]pyridine 3b.
The product 3b was prepared according to the general procedure
described herein with CBr4 (352 mg, 1.06 mmol, 2.0 equiv) as
electrophile. Purification by centrifugal thin-layer chromatography was
performed with cyclohexane/AcOEt: 10/0 as eluent and led to the
expected compound 3b (route A: 61 mg, 38%; route B: 142 mg, 88%)
1
NMR δH (ppm) 0.88 (t, J = 7.3 Hz, 9H); 1.24−1.39 (m, 12H); 1.55−
1.62 (m, 6H); 7.12 (dd, J = 8.2 Hz, J′ = 4.8 Hz, 1H); 7.62 (dd, J = 8.2
Hz, J′ = 1.4 Hz, 1H); 8.46 (dd, J = 4.8 Hz, J′ = 1.4 Hz, 1H). 13C NMR
δC (ppm) 10.2 (3C); 13.8 (3C); 27.3 (3C); 29.2 (3C); 111.9; 116.7;
118.5; 145.9; 147.9; 150.2; 154.5. MS (EI) m/z 386 ([M-57]+, 68);
328 (13); 272 (100). ESI-HRMS calcd for C19H30ClNNaOSn (M +
Na)+: 466.0927; found: 466.0917.
1-(2-Chlorofuro[3,2-b]pyridin-3-yl)-1-phenylmethanol 2d.
The product 2d was prepared according to the general procedure
described herein with benzaldehyde (170 mg, 1.6 mmol, 2.0 equiv) as
electrophile. Purification by centrifugal thin-layer chromatography was
performed with cyclohexane/AcOEt: 8/2 to 7/3 as eluent and led to
the expected compound 2d (166 mg, 80%) as beige solid: mp 80−83
°C. 1H NMR δH (ppm) 4.90 (br s, 1H); 6.06 (s, 1H); 7.18 (dd, J = 8.4
Hz, J′ = 4.9 Hz, 1H); 7.24−7.36 (m, 3H); 7.53−7.58 (m, 2H); 7.64
(dd, J = 8.4 Hz, J′ = 1.3 Hz, 1H); 8.45 (dd, J = 4.9 Hz, J′ = 1.3 Hz,
1H). 13C NMR δC (ppm) 69.5; 117.9; 118.1; 119.4; 126.3 (2C);
127.9; 128.6 (2C); 142.2; 142.4; 145.8; 146.7; 146.9. MS (EI) m/z
259 ([M]+, 50); 182 (100); 153 (23). ESI-HRMS calcd for
C14H10ClNNaO2 (M + Na)+: 282.0292; found: 282.0291.
1
as an orange solid: mp 42−45 °C. H NMR δH (ppm) 0.46 (s, 9H);
7.33 (d, J = 5.1 Hz, 1H); 8.29 (d, J = 5.1 Hz, 1H). 13C NMR δC (ppm)
−0.8 (3C); 112.4; 122.3; 122.6; 146.3; 146.5; 150.3; 153.1. MS (EI)
m/z 305 ([M + 2]+, 26); 303 ([M]+, 19); 290 (100); 288 (78); 268
(15). ESI-HRMS calcd for C10H12BrClNOSi (M + H)+: 303.9555;
found: 303.9544.
2-Chloro-7-tri-n-butylstannyl-3-trimethylsilylfuro[3,2-b]-
pyridine 3c. The product 3c was prepared according to the general
procedure described herein with chlorotri-n-butyltin (345 mg, 1.06
mmol, 2.0 equiv) as electrophile. Purification by centrifugal thin-layer
chromatography was performed with cyclohexane/AcOEt: 10/0 to 98/
2 as eluent and led to the expected compound 3c (route A: 150 mg,
55%; route B: 237 mg, 87%) as a colorless liquid: 1H NMR δH (ppm)
0.47 (s, 9H); 0.89 (t, J = 7.3 Hz, 9H); 1.18−1.23 (m, 6H); 1.29−1.39
(m, 6H); 1.53−1.61 (m, 6H); 7.19 (d, J = 4.6 Hz, 1H); 8.40 (d, J = 4.6
Hz, 1H). 13C NMR δC (ppm) −0.5 (3C); 10.2 (3C); 13.8 (3C); 27.4
(3C); 29.1 (3C); 111.3; 126.5; 131.7; 144.9; 149.2; 149.8; 154.6. MS
(EI) m/z 458 ([M-57]+, 100); 402 (81); 346 (90); 210 (41); 73 (56).
ESI-HRMS calcd for C22H39ClNOSiSn (M + H)+: 516.1503; found:
516.1490.
1-(2-Chloro-3-trimethylsilylfuro[3,2-b]pyridin-7-yl)-1-phe-
nylmethanol 3d. The product 3d was prepared according to the
general procedure described herein with benzaldehyde (112 mg, 1.06
mmol, 2.0 equiv) as electrophile. Purification by centrifugal thin-layer
chromatography was performed with cyclohexane/AcOEt: 10/0 to 95/
5 as eluent and led to the expected compound 3d (route A: 81 mg,
46%; route B: 158 mg, 90%) as a yellow gummy: 1H NMR δH (ppm)
0.44 (s, 9H); 2.65 (br s, 1H); 6.25 (s, 1H); 7.29−7.37 (m, 3H); 7.46−
7.49 (m, 2H); 8.48 (d, J = 5.1 Hz, 1H). 13C NMR δC (ppm) −0.7
(3C); 70.6; 115.5; 126.6 (2C); 128.3; 128.8 (2C); 134.4; 141.6; 144.5;
146.3; 147.8; 149.6; 152.4. MS (EI) m/z 331 ([M]+, 53); 316 (100);
296 (58). ESI-HRMS calcd for C17H19ClNO2Si (M + H)+: 332.0868;
found: 332.0861.
2,3-Dichlorofuro[3,2-b]pyridine 2e. The product 2e was
prepared according to the general procedure described herein with
C2Cl6 (379 mg, 1.6 mmol, 2.0 equiv) as electrophile. Purification by
centrifugal thin-layer chromatography was performed with cyclo-
hexane/AcOEt: 10/0 to 95/5 as eluent and led to the expected
1
compound 2e (117 mg, 78%) as a white powder: mp 57−60 °C. H
NMR δH (ppm) 7.31 (dd, J = 8.4 Hz, J′ = 4.8 Hz, 1H); 7.73 (dd, J =
8.4 Hz, J′ = 1.2 Hz, 1H); 8.60 (dd, J = 4.8 Hz, J′ = 1.2 Hz, 1H). 13C
NMR δC (ppm) 109.8; 118.5; 120.4; 142.6; 144.0; 146.4; 147.1. MS
(EI) m/z 189 ([M + 2]+, 60); 187 ([M]+, 94); 159 (46); 126 (33);
124 (100). ESI-HRMS calcd for C7H3Cl2NNaO (M + Na)+:
209.9484; found: 209.9484.
Lithiation of 2-Chloro-3-trimethylsilylfuro[3,2-b]pyridine 2a
with n-BuLi or LiTMP: Preparation of Compounds 3a−g.
General Procedure with n-BuLi, Route A. To a solution of 2-chloro-3-
trimethylsilylfuro[3,2-b]pyridine 2a (120 mg, 0.53 mmol, 1.0 equiv) in
THF (10 mL) was added dropwise n-BuLi (0.4 mL, 0.64 mmol, 1.2
equiv) at −20 °C, under argon atmosphere. After stirring for 1 h at
−20 °C, the appropriate electrophile (1.06 mmol, 2.0 equiv) was
added in THF (5 mL) at −20 °C. The temperature was then allowed
to warm to 20 °C over 20 min. After stirring for 40 min at 20 °C, the
hydrolysis was performed with H2O (10 mL) at 20 °C. The aqueous
layer was then extracted twice with AcOEt (2 × 10 mL). After drying
(MgSO4), filtration and solvent evaporation, the crude product was
purified by centrifugal thin-layer chromatography.
2,7-Dichloro-3-trimethylsilylfuro[3,2-b]pyridine 3e. The
product 3e was prepared according to the general procedure described
in route B with hexachloroethane (251 mg, 1.06 mmol, 2.0 equiv) as
electrophile. Purification by centrifugal thin-layer chromatography was
performed with cyclohexane/AcOEt: 10/0 to 95/5 as eluent and led to
the expected compound 3e (127 mg, 92%) as a white solid: mp 48−50
1
°C. H NMR δH (ppm) 0.46 (s, 9H); 7.19 (d, J = 5.3 Hz, 1H); 8.39
(d, J = 5.3 Hz, 1H). 13C NMR δC (ppm) −0.8 (3C); 112.4; 119.4;
124.8; 144.5; 146.3; 150.5; 153.7. MS (EI) m/z 259 ([M]+, 25); 244
(100); 224 (15); 73 (35). ESI-HRMS calcd for C10H12Cl2NOSi (M +
H)+: 260.0060; found: 260.0042.
General Procedure with LiTMP, Route B. To a solution of LiTMP
(3.4 mL, 0.31M, 1.06 mmol, 2.0 equiv) in THF was added dropwise 2-
chloro-3-trimethylsilylfuro[3,2-b]pyridine 2a (120 mg, 0.53 mmol, 1.0
equiv) in THF (10 mL) at −20 °C, under argon atmosphere. After
stirring for 1 h at −20 °C, the appropriate electrophile (1.06 mmol, 2.0
equiv) was added in THF (5 mL) at −20 °C. The temperature was
then allowed to warm to 20 °C over 20 min. After stirring for 40 min
at 20 °C, the hydrolysis was performed with H2O (10 mL) at 20 °C.
The aqueous layer was then extracted twice with AcOEt (2 × 10 mL).
After drying (MgSO4), filtration and solvent evaporation, the crude
product was purified by centrifugal thin-layer chromatography.
2-Chloro-3,7-bis(trimethylsilyl)furo[3,2-b]pyridine 3a. The
product 3a was prepared according to the general procedure described
herein with TMSCl (115 mg, 1.06 mmol, 2.0 equiv) as electrophile.
Purification by centrifugal thin-layer chromatography was performed
with cyclohexane/AcOEt: 10/0 as eluent and led to the expected
compound 3a (route A: 63 mg, 40%; route B: 123 mg, 78%) as a white
2-Chloro-7-methylthio-3-trimethylsilylfuro[3,2-b]pyridine
3f. The product 3f was prepared according to the general procedure
described in route B with dimethyldisulfide (100 mg, 1.06 mmol, 2.0
equiv) as electrophile. Purification by centrifugal thin-layer chroma-
tography was performed with cyclohexane/AcOEt: 10/0 to 95/5 as
eluent and led to the expected compound 3f (97 mg, 67%) as a yellow
1
oil: H NMR δH (ppm) 0.45 (s, 9H); 2.61 (s, 3H); 6.95 (d, J = 5.25
Hz, 1H); 8.35 (d, J = 5.25 Hz, 1H). 13C NMR δC (ppm) −0.7 (3C);
14.1; 111.6; 114.1; 114.8; 131.3; 145.8; 149.1; 151.2. MS (EI) m/z 271
([M]+, 57); 256 (100); 236 (55); 73 (59). ESI-HRMS calcd for
C11H15ClNOSSi (M + H)+: 272.0327; found: 272.0332.
2-Chloro-7-formyl-3-trimethylsilylfuro[3,2-b]pyridine 3g.
The product 3g was prepared according to the general procedure
described in route B with dimethylformamide (77 mg, 1.06 mmol, 2.0
equiv) as electrophile. Purification by centrifugal thin-layer chroma-
tography was performed with cyclohexane/AcOEt 10/0 to 95/5 as
eluent and led to the expected compound 3g (114 mg, 85%) as a white
solid: mp 73−75 °C. 1H NMR δH (ppm) 0.47 (s, 9H); 7.53 (d, J = 5
Hz, 1H); 8.71 (d, J = 5 Hz, 1H); 10.51 (s, 1H). 13C NMR δC (ppm)
−0.8 (3C); 111.6; 115.6; 123.8; 145.2; 146.7; 151.6; 155.5; 187.8. MS
1
solid: mp 42−44 °C. H NMR δH (ppm) 0.41 (s, 9H); 0.46 (s, 9H);
7.17 (d, J = 4.7 Hz, 1H); 8.46 (d, J = 4.7 Hz, 1H). 13C NMR δC (ppm)
−1.4 (3C); −0.6 (3C); 110.9; 123.3; 130.5; 145.0; 149.5; 150.6; 152.4.
MS (EI) m/z 297 ([M]+, 26); 282 (47); 262 (30); 93 (24); 73 (100).
ESI-HRMS calcd for C13H21ClNOSi2 (M + H)+ 298.0845; found:
298.0851.
G
dx.doi.org/10.1021/jo400748n | J. Org. Chem. XXXX, XXX, XXX−XXX